Vasculitis & polymyalgia rheumatica

Color Doppler carotid resistance, pulsatility, and aortic oscillometry indices in giant cell arteritis: insights from the VASCARD cohort

Arthritis Res TherPublished Cross-sectional study

Authors' conclusion

GCA patients demonstrated increased carotid pulsatility, resistance, atherosclerosis, and aortic stiffness compared to controls.

Study context

Population
Patients with giant cell arteritis (GCA) and healthy controls (VASCARD cohort)
Participants
66 vs 93
Exposure
GCA patients vs healthy controls
  • GCAn = 66
  • Controlsn = 93reference
Outcome
Color Doppler ultrasound (CDUS), greyscale ultrasound (GSUS) and oscillometric indices, GCA vs controls
Methodological detailscase-control comparison with healthy controls
  • Case-control comparison with healthy controls

Main finding

As reported in the abstract

  • GCA vs Controls: padj <0.001
  • GCA vs Controls: padj =0.037
  • GCA vs Controls: padj =0.009
  • GCA vs Controls: padj=0.019
  • GCA vs Controls: P < 0.001

Observational data: associations, not effects.

Further findings

Correlates of carotid-femoral pulse-wave velocity (cfPWV) (traditional CV risk factors)

Age, rho = 0.330
P < 0.009
Mean arterial pressure, rho = 0.257
P = 0.044
Cholesterol, rho = 0.318
P = 0.017

CCA-PI and CCA-RI by immunosuppressive therapy (GCA patients)

CCA-PI lower with vs without immunosuppressive therapy: 1.5 (1.33-2.04) vs. 1.95 (1.72-2.29)
P < 0.05
CCA-RI lower with vs without immunosuppressive therapy: 0.74 (0.68-0.82) vs. 0.80 (0.76-0.85)
P < 0.05

CCA-RI predicted by ESR

ESR, rho = 0.343
P = 0.044

Correlates of carotid intima-media-thickness (cIMT)

Age, r = 0.619
P < 0.001
Plaque area, rho = 0.305
P = 0.047

Original publication

Color Doppler carotid resistance, pulsatility, and aortic oscillometry indices in giant cell arteritis: insights from the VASCARD cohort. Arthritis Res Ther. Published 28 March 2026. doi:10.1186/s13075-026-03779-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.